Cullinan Oncology
CGEM
CGEM
97 hedge funds and large institutions have $396M invested in Cullinan Oncology in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
1% less funds holding
Funds holding: 98 → 97 (-1)
15% less capital invested
Capital invested by funds: $466M → $396M (-$70.4M)
Holders
97
Holding in Top 10
4
Calls
$13K
Puts
$3K
Top Buyers
| 1 | +$2.07M | |
| 2 | +$1.98M | |
| 3 | +$1.95M | |
| 4 |
BlackRock
New York
|
+$1.39M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.39M |
Top Sellers
| 1 | -$5.51M | |
| 2 | -$1.68M | |
| 3 | -$1.14M | |
| 4 |
Morgan Stanley
New York
|
-$667K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$520K |